Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer
JAMA Network Open · 09.01.2024 · 7 (1) · e2350844
DOI: 10.1001/jamanetworkopen.2023.50844 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 09.01.2024. Verfasst von Sheetal Kircher und 16 weiteren Autor:innen. Beteiligte Einrichtung: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois. Hauptthemen laut MEDLINE: Rectal Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Importance The longitudinal experience of patients is critical to the development of interventions to identify and reduce financial hardship.
Objective
To evaluate financial hardship over 12 months in patients with newly diagnosed colorectal cancer (CRC) undergoing curative-intent therapy. Design, Setting, and Participants This prospective, longitudinal cohort study was conducted between May 2018 and July 2020, with time points over 12 months. Participants included patients at National Cance Institute Community Oncology Research Program sites. Eligibility criteria included age at least 18 years, newly diagnosed stage I to III CRC, not started chemotherapy and/or radiation, treated with curative intent, and able to speak English. Data were analyzed from December 2022 through April 2023. Main Outcomes and Measures The primary end point was financial hardship, measured using the Comprehensive Score for Financial Toxicity (COST), which assesses the psychological domain of financial hardship (range, 0-44; higher score indicates better financial well-being). Participants completed 30-minute surveys (online or paper) at baseline and 3, 6, and 12 months.
Results
A total of 450 participants (mean [SD] age, 61.0 [12.0] years; 240 [53.3%] male) completed the baseline survey; 33 participants (7.3%) were Black and 379 participants (84.2%) were White, and 14 participants (3.1%) identified as Hispanic or Latino and 424 participants (94.2%) identified as neither Hispanic nor Latino. There were 192 participants (42.7%) with an annual household income of $60 000 or greater. There was an improvement in financial hardship from diagnosis to 12 months of 0.3 (95% CI, 0.2 to 0.3) points per month ( P < .001). Patients with better quality of life and greater self-efficacy had less financial toxicity. Each 1-unit increase in Functional Assessment of Cancer Therapy–General (rapid version) score was associated with an increase of 0.7 (95% CI, 0.5 to 0.9) points in COST score ( P < .001); each 1-unit increase in self-efficacy associated with an increase of 0.6 (95% CI, 0.2 to 1.0) points in COST score ( P = .006). Patients who lived in areas with lower neighborhood socioeconomic status had greater financial toxicity. Neighborhood deprivation index was associated with a decrease of 0.3 (95% CI, −0.5 to −0.1) points in COST score ( P = .009). Conclusions and Relevance These findings suggest that interventions for financial toxicity in cancer care should focus on counseling to improve self-efficacy and mitigate financial worry and screening for these interventions should include patients at higher risk of financial burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.
- Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island.
- Center for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island.
- Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island.
- University of California School of Medicine, Irvine.
- Kaiser Permanente NCI Community Oncology Research Program and NCORP, Vallejo, California.
Förderung
- NCI NIH HHS
Zitieren
APA
Kircher, S., Duan, F., An, N., Gareen, I. F., Sicks, J. D., Sadigh, G., Suga, J. M., Kehn, H., Mehan, P. T., Bajaj, R., Hanson, D. S., Dalia, S. M., Acoba, J. D., Yasar, D. G., Park, E. R., Wagner, L. I., & Carlos, R. C. (2024). Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA Network Open, 7(1), e2350844. https://doi.org/10.1001/jamanetworkopen.2023.50844
Vancouver
Kircher S, Duan F, An N, Gareen IF, Sicks JD, Sadigh G, et al. Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer. JAMA Network Open. 2024;7(1):e2350844. doi:10.1001/jamanetworkopen.2023.50844
BibTeX
@article{Kircher2024,
author = {Kircher, Sheetal and Duan, Fenghai and An, Na and Gareen, Ilanan F and Sicks, JoRean D and Sadigh, Gelareh and Suga, Jennifer M and Kehn, Heather and Mehan, Paul T and Bajaj, Rajesh and Hanson, David S and Dalia, Samir M and Acoba, Jared D and Yasar, Demet Gokalp and Park, Elyse R and Wagner, Lynne I and Carlos, Ruth C},
title = {Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {1},
pages = {e2350844},
doi = {10.1001/jamanetworkopen.2023.50844}
}
EUVIMED